Clinical Trial Update: Bone Marrow Aspirate Concentrate (BMAC) Treatment for Knee Osteoarthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Bone Marrow Aspirate Concentrate (BMAC) for knee osteoarthritis is not yet recruiting, sponsored by CELL Technologies Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Musculoskeletal Diseases

Drugs mentioned

• Bone Marrow Aspirate Concentrate (BMAC) (bone marrow aspirate concentrate)

Snippet

Sponsor: CELL Technologies Inc. | Conditions: Knee Osteoarthritis, Musculoskeletal Diseases | Phase 3 | Status: NOT_YET_RECRUITING